Ferroptosis in cardiovascular disease: regulatory mechanisms and therapeutic implications

Yiheng Zhao1, Andreas Linkermann2,3,4, Masafumi Takahashi5

  • 1Department of Cardiology, The Second Affiliated Hospital of Nanjing Medical University, No. 121 Jiangjiayuan, Nanjing 210011, China.

PubMed

Insights

Ferroptosis, an iron-dependent cell death, drives cardiovascular diseases (CVDs). Targeting ferroptosis with new therapies offers a promising strategy for treating CVDs.

Area of Science:

  • Biomedical Science
  • Cardiovascular Research
  • Cell Death Mechanisms

Background:

  • Ferroptosis, a regulated cell death pathway dependent on iron, plays a critical role in cardiovascular disease (CVD) development and progression.
  • Key molecular mechanisms include lipid peroxidation, iron metabolism dysregulation, and antioxidant system involvement.

Purpose of the Study:

  • To review and synthesize current knowledge on ferroptosis in CVDs.
  • To summarize the complex regulatory mechanisms and functions of ferroptosis in various cardiovascular conditions.
  • To provide an overview of emerging ferroptosis-targeting therapeutic strategies for CVDs.

Main Methods:

  • Literature review and synthesis of existing research on ferroptosis and cardiovascular diseases.
  • Analysis of molecular pathways, including lipid peroxidation, iron dysregulation, and antioxidant systems.
  • Examination of therapeutic approaches, including inhibitors, drug repurposing, natural compounds, and targeted delivery systems.

Main Results:

  • Ferroptosis is implicated in atherosclerosis, myocardial ischemia-reperfusion injury, cardiac hypertrophy, and cardiomyopathies.
  • Novel therapeutic strategies targeting ferroptosis are emerging, including repurposed drugs and natural compounds.
  • Targeted drug delivery systems show potential for enhanced ferroptosis inhibition.

Conclusions:

  • Ferroptosis is a significant contributor to the pathogenesis of diverse cardiovascular diseases.
  • Targeting ferroptosis presents a novel and promising therapeutic avenue for CVD treatment.
  • Further research into ferroptosis mechanisms and therapies could revolutionize cardiovascular medicine.

Related Concept Videos

Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
2.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
44
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
816
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
59
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K